‹ Back to EMCURE.NS

EMCURE.NS Balance Sheet

Emcure Pharmaceuticals Ltd.

Profit & Loss Balance Sheet Cash Flow

Balance Sheet · 2 years on file (FY2024-25 to FY2025-26) · fetched 2026-08-24 01:34
Line item FY2024-25 FY2025-26 Source (XBRL element)
Property, Plant and Equipment ₹1,953.60 Cr. ₹1,959.93 Cr. PropertyPlantAndEquipment
Capital Work-in-Progress ₹124.06 Cr. ₹172.06 Cr. CapitalWorkInProgress
Goodwill ₹367.77 Cr. ₹414.26 Cr. Goodwill
Other Intangible Assets ₹875.36 Cr. ₹945.03 Cr. OtherIntangibleAssets
Non-current Investments ₹19.34 Cr. ₹19.70 Cr. NoncurrentInvestments
Other Non-current Assets ₹38.89 Cr. ₹111.21 Cr. OtherNoncurrentAssets
Total Non-current Assets ₹3,582.82 Cr. ₹3,903.45 Cr. NoncurrentAssets
Inventories ₹1,931.81 Cr. ₹2,397.87 Cr. Inventories
Trade Receivables ₹2,002.24 Cr. ₹2,562.66 Cr. TradeReceivablesCurrent
Cash and Cash Equivalents ₹155.54 Cr. ₹136.66 Cr. CashAndCashEquivalents
Current Investments ₹76.04 Cr. ₹0.00 Cr. CurrentInvestments
Other Current Assets ₹327.95 Cr. ₹435.31 Cr. OtherCurrentAssets
Total Current Assets ₹4,649.90 Cr. ₹5,709.03 Cr. CurrentAssets
Total Assets ₹8,232.72 Cr. ₹9,612.48 Cr. Assets
Equity Share Capital ₹189.48 Cr. ₹189.59 Cr. EquityShareCapital
Other Equity ₹4,256.70 Cr. ₹4,760.44 Cr. OtherEquity
Equity Attributable to Owners ₹4,446.19 Cr. ₹4,950.03 Cr. EquityAttributableToOwnersOfParent
Non-controlling Interests ₹195.37 Cr. ₹26.64 Cr. NonControllingInterest
Total Equity ₹4,641.55 Cr. ₹4,976.67 Cr. Equity
Long-term Borrowings ₹189.94 Cr. ₹252.21 Cr. BorrowingsNoncurrent
Total Non-current Liabilities ₹922.90 Cr. ₹723.57 Cr. NoncurrentLiabilities
Short-term Borrowings ₹541.77 Cr. ₹951.87 Cr. BorrowingsCurrent
Trade Payables ₹1,479.58 Cr. ₹1,807.77 Cr. TradePayablesCurrent
Other Current Liabilities ₹120.58 Cr. ₹96.53 Cr. OtherCurrentLiabilities
Total Current Liabilities ₹2,668.27 Cr. ₹3,912.24 Cr. CurrentLiabilities
Total Equity and Liabilities ₹8,232.72 Cr. ₹9,612.48 Cr. EquityAndLiabilities

Every figure above is the exact value of the named XBRL element from EMCURE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).